Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma

Advanced natural killer/T cell lymphoma (NKTL) has demonstrated poor prognosis with currently available therapies. Here, we report the efficacy of anti-programmed death 1 (PD-1) antibody with the P-GEMOX (pegaspargase, gemcitabine, and oxaliplatin) regimen in advanced NKTL. Nine patients underwent s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jun, Liu, Panpan, Huang, Huiqiang, Li, Yajun, Ma, Shuyun, Zhou, Hui, Tian, Xiaopeng, Zhang, Yuchen, Gao, Yan, Xia, Yi, Zhang, Xuanye, Yang, Hang, Li, Lirong, Cai, Qingqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772337/
https://www.ncbi.nlm.nih.gov/pubmed/33376237
http://dx.doi.org/10.1038/s41392-020-00331-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772337/
https://www.ncbi.nlm.nih.gov/pubmed/33376237
http://dx.doi.org/10.1038/s41392-020-00331-3

Ejemplares similares